Viewing Study NCT03215095

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:00 PM
Ignite Modification Date: 2026-02-20 @ 7:24 PM
Study NCT ID: NCT03215095
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-17
First Post: 2017-07-11
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thyroid Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Radioiodine (RAI) View
None Durvalumab (Medi4736) View
None RAI-avid View
None 17-218 View